BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Kinex Pharmaceuticals Announces that the US FDA Allows Their IND to Begin KX02 Clinical Trials

  June 4, 2013

   · 

  3 min read
• Basilea Pharmaceutica Presents First Phase 1 Data From Its Novel Anti-Cancer Drug BAL101553 at American Society of Clinical Oncology Conference

  June 4, 2013

   · 

  4 min read
• BioMidwest

  Navidea Biopharmaceuticals Announces Data Presentations at 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)

  June 4, 2013

   · 

  1 min read
• Policy

  FDA Grants Priority Review to Bristol-Myers Squibb Company and AstraZeneca PLC’s Metreleptin, an Investigational Agent for Treatment of Metabolic Disorders Associated With Rare Forms of Lipodystrophy

  June 4, 2013

   · 

  1 min read
• BioMidwest

  Neuros Medical, Inc.l Announces Successful Pilot Study: Data to Be Presented at International Neuromodulation Society’s World Congress

  June 4, 2013

   · 

  1 min read
• Drug Development

  Zalicus Inc. Advancing Clinical Development of Z944, Its Novel, Oral, T-Type Calcium Channel Blocker, for the Treatment of Pain

  June 4, 2013

   · 

  1 min read
• Genetown

  Acceleron Pharma Named to the “Best Places to Work” List by The Scientist Magazine

  June 4, 2013

   · 

  1 min read
• BioMidwest

  American Medical Systems, Inc. Release: First Head-to-Head Study Shows Greenlight XPS® Laser Therapy Equally Safe and Effective With Faster Recovery as Commonly Used Turp for Treatment of BPH

  June 4, 2013

   · 

  1 min read
• Pharm Country

  Suneva Medical Selects Quinnova Pharmaceuticals, Inc. to Co-Promote ReFissa®--Topical Rx Facial Skin Care Treatment

  June 4, 2013

   · 

  2 min read
• Drug Development

  Tesaro, Inc. Details Niraparib Phase 1 Clinical Data Presented at the 2013 American Society of Clinical Oncology Annual Meeting

  June 4, 2013

   · 

  1 min read